Bone Marrow Transplantation to Promote Follicle Recruitment in Poor Ovarian Reserve
Study Details
Study Description
Brief Summary
Women delay maternity and, as a consequence, available oocyte number and their quality decrease (9-18% of all IVF patients). Different treatment protocols have been developed nevertheless none of them optimal: the number of oocytes retrieved depends on the present ones. New generation of oocytes and follicles has been defended by some authors and bone marrow seems to be involved. What seems crucial is the niche that produces paracrine signals able to activate dormant cells and to attract undifferentiated cells from other tissues (homing). This phenomenon has been described by our group in other human reproductive tissues like endometrium. The purpose of the study is to improve ovarian reserve in unfertile women with poor ovarian reserve by means of bone marrow protective capacity.
Bone marrow progenitor cells will be delivered into the ovarian artery allowing them to colonize ovarian niche.
The study hypothesis is that bone marrow progenitor cells will improve ovarian reserve differentiating themselves into germ cells or, more likely, stimulating the niche to activate dormant follicles.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Poor ovarian reserve women
|
Drug: Bone marrow transplant into ovarian artery
Bone marrow progenitors mobilized to peripheral blood, obtained by plasmapheresis and infused into the ovarian artery
|
Outcome Measures
Primary Outcome Measures
- Ovarian reserve [6 months]
Measured by FSH-LH, oestradiol, AMH, antral follicle count
Secondary Outcome Measures
- Ovarian response to controlled ovarian stimulation [6 months]
Number of MII oocytes obtained
Other Outcome Measures
- Take home baby [2 years]
healthy new born after controlled ovarian stimulation, ICSI and ET.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
< or= 40 years old
-
FSH<15UI/L
-
poor ovarian response after controlled ovarian stimulation with conventional doses (<3 oocytes) or two episodes of poor ovarian response after ovarian stimulation with maximal doses even if young or normal ovarian reserve study.
-
Antral follicle count>2
-
1 antral follicle in the perfused ovary
-
AMH between 0,5 and 3pmol/L
-
regular menstrual bleeding each 21-35 days
-
To be candidate to autologous hematopoietic progenitors transplantation
Exclusion Criteria:
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Hospital Universitario La fe | Valencia | Spain | 46026 |
Sponsors and Collaborators
- Hospital Universitario La Fe
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- NEOFOL2014